Moderna, Inc. wani kamfanin fasahar kere-kere da ke sahun gaba na manzo RNA (mRNA) warkewa da alluran rigakafi, ya sanar da cewa ya ƙaddamar da aikace-aikacen tsari ga Hukumar Kula da Magunguna ta Turai (EMA) don sabunta rigakafin COVID-19 da ke ɓoye furotin mai kauri na layin XBB.1.5. SARS-CoV-2.
Stéphane Bancel, Babban Jami’in Moderna ya ce “Muna alfaharin sanar da wannan shigar don sabunta rigakafin COVID-19 kuma muna ci gaba da tallafawa Tarayyar Turai don kare ‘yan ƙasa daga COVID-19.”
“Gwajin mu na farko na asibiti ya nuna cewa sabbin rigakafin COVID-19 namu yana da tasiri wajen samar da martanin rigakafi ga bambance-bambancen XBB na yanzu, kuma mun yi imanin zai taka muhimmiyar rawa wajen kare kai daga kamuwa da cuta mai tsanani da kuma asibiti. Muna fatan yin aiki tare da EMA don kawo sabbin rigakafinmu ga mutane a duk faɗin Tarayyar Turai. “
Aikace-aikacen ya dogara ne akan jagora daga Cibiyar Kariya da Kula da Cututtuka ta Turai (ECDC) da EMA, waɗanda suka ba da shawarar cewa a sabunta allurar COVID-19 zuwa ƙayyadaddun tsarin XBB.1.5. Wannan ya yi daidai da sauran masu gudanarwa da hukumomin kiwon lafiyar jama’a na duniya suna ba da shawarar haɗakar XBB.1.5 guda ɗaya. Bugu da ƙari, Moderna ya ƙirƙira bayanan asibiti na farko na ɗan takarar rigakafinta na XBB.1.5 wanda ke nuna martanin rigakafi ga zuriyar XBB kamar XBB.1.5, XBB.1.16, da XBB.2.3.2.
Moderna yana kan aiwatar da ƙaddamar da bayanai ga masu gudanarwa a duk duniya don haɓaka sabbin rigakafin COVID-19 a cikin lokacin lokacin kaka/hunturu kuma ya shigar da ƙara kwanan nan tare da Hukumar Abinci da Magunguna ta Amurka, Health Canada, da sauran hukumomin kiwon lafiya.
L.N
Leave a Reply